Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial Active Biotech, 25 Jun 2015 Accessed on 30 Jun 2015 from https://www.activebiotech.com/press-releases-1?pressid=1931462. CommentRecommendBookmarkWatch